HIV, Pregnancy and a Digital Comic
|
Integrated Care Model for HIV/STI Prevention and HCV Treatment Initiation in a Residential SUD Treatment Program: Current Practices and Challenges
|
Expansion of HIV Pre-Exposure Prophylaxis Utilizing Pharmacy-led Clinic at Veterans Affairs Health-System
|
Multidisciplinary Management of Substance Use Disorder in People Living with HIV treated in a Medical Home Model of Care
|
Increased Patient Adherence to Pre-exposure Prophylaxis (PrEP) after Implementation of a Pharmacy Supported PrEP Program
|
PrEP use trend and assessment of factors that may affect PrEP persistence
|
Clinical Pharmacy: PrEPing for the Future of HIV Prevention at a Large Academic Veterans Affairs Medical Center
|
Implementing a standard operating procedure for PrEP increased provider comfort, knowledge and prescribing in a Georgia residency program
|
Characteristics of Early Adopters of a Two-Drug Regimen (Dolutegravir/Lamivudine) for Treatment of Human Immunodeficiency Virus Type 1 (HIV-1) in a Real-World Setting
|
Prevalence of Polypharmacy and Medication use Contraindicated during Pregnancy among a Cohort of Women Living with HIV who are of Childbearing Age, 2016-2017
|
Cabotegravir + Rilpivirine Every 2 Months is Noninferior to Monthly: Atlas-2M Study
|
Headache and Lung Mass in the HIV Positive Patient
|
| Feasibility, Efficacy, and Safety of Using Dolutegravir/Lamivudine (DTG/3TC) as a First-Line Regimen in a Test-and-Treat Setting for Newly Diagnosed People Living with HIV (PLWH): The STAT Study |
